Keyphrases
Thyroid Cancer
100%
Squamous Cell Carcinoma (SqCC)
70%
Head-and-neck
62%
Thyroid Cancer Cells
59%
Vesicular Stomatitis Virus
56%
Interleukin-12 (IL-12)
51%
Androgen Signaling
50%
Androgen Receptor
43%
Treatment Outcome
42%
Intensity-modulated Radiation Therapy
40%
Nasopharyngeal Carcinoma
37%
Senescence
37%
Papillary Thyroid Carcinoma
37%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
37%
Thyroid Carcinoma Cells
37%
Papillary Thyroid Cancer
33%
Overall Survival
33%
Androgens
31%
Estrogen
31%
Angiography
31%
Floor of Mouth
29%
United States
28%
Surgical Approach
25%
Head-and-neck Cancer
25%
Oncolytic Virus
25%
Radiograph
23%
Therapeutic Target
22%
Parotid Salivary Gland
22%
American Joint Committee on Cancer
22%
Surveillance Epidemiology
22%
Cancer Stage
22%
Intraoperative Radiation Therapy
22%
Chemotherapy
22%
Virus
21%
Diagnostic Evaluation
21%
Clinical Review
21%
Fusogenic
20%
Thyroid Cells
20%
PD-L1 Downregulation
18%
Salivary Gland Cancer
18%
Proliferative Disorder
18%
Trends in Management
18%
Granulocyte Colony-stimulating Factor (G-CSF)
18%
Sudden Sensorineural Hearing Loss (SSNHL)
18%
Sensorineural
18%
Intensity-modulated Radiotherapy
18%
Surgeons
18%
Laboratory Evaluation
18%
Advanced Laryngeal Cancer
18%
BRAF V600E
18%
Medicine and Dentistry
Cancer Cell
76%
Thyroid Cancer
75%
Neck
62%
Intensity Modulated Radiation Therapy
59%
Squamous Cell Carcinoma
43%
Neoplasm
40%
Nasopharynx Carcinoma
37%
Vesiculovirus
37%
Papillary Thyroid Carcinoma Cell
37%
Androgen Receptor
37%
Interleukin 12
37%
Papillary Thyroid Cancer
37%
Diagnosis
35%
Malignant Neoplasm
34%
Overall Survival
33%
Surgical Approach
31%
Carcinoma
29%
Angiography
28%
Floor of Mouth
26%
Head and Neck Cancer
24%
Squamous Cell
23%
Health Care Cost
22%
Magnetic Resonance Imaging
22%
Salivary Gland
22%
In Vitro
21%
Computer Assisted Tomography
20%
Radiation Therapy
19%
Focal Adhesion Kinase
18%
Downregulation
18%
Salivary Gland Cancer
18%
Urokinase Receptor
18%
Urokinase
18%
Laboratory Test
18%
Sensorineural Hearing Loss
18%
Upper Airway Resistance Syndrome
18%
Synovial Sarcoma
18%
Thyroglossal Cyst
18%
Akt Signaling
18%
Cylindroma
18%
Surgeon
18%
Laryngeal Cancer
18%
CD137 Ligand
18%
Epistaxis
18%
Symptom
18%
Treatment Planning
18%
Thyroidectomy
18%
Phosphoinositide 3-Kinase
18%
Cancer Staging
18%
Disease
18%
Cancer Growth
18%